Finland· FI-REL-REL3270

Soldactone

A potassium canrenoate product, registered in Finland by Searle Scandinavia Division of Monsanto Sverige AB. The same ATC class is registered in 9 of our 19 countries.

ATC C03DA02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSoldactoneATCC03DA02REGISTER NO.FI-REL-REL3270PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Potassium canrenoate is registered in 9 of 19 countries.

Countries holding a registration under ATC C03DA02 (potassium canrenoate), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 6 of them publish a price we can compare per daily dose

Potassium canrenoate · ATC C03DA02

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Germany
  • Italyprice
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of potassium canrenoate costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Potassium canrenoate · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • IT Italy$0.82
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Manufacturer
Searle Scandinavia Division of Monsanto Sverige AB
Country
Finland (FI)
ATC code
C03DA02
ATC class
Potassium canrenoate
Defined daily dose
0.4 g, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for potassium canrenoate.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Potassium canrenoate · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f699168c-3ad6-409c-bcac-dd43ce982423
GET /v1/drugs/f699168c-3ad6-409c-bcac-dd43ce982423?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.4",
  "form": "injektiokuiva-aine, liuosta varten",
  "route": null,
  "ddd_unit": "g",
  "strength": "200 mg",
  "atc_label": "kaliumkanrenoaatti",
  "ma_number": "10822",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL3270",
  "authorised_at": "1992-11-18"
}

See everything about potassium canrenoate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.